185 related articles for article (PubMed ID: 20947286)
1. Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot study.
Hays JT; Croghan IT; Schroeder DR; Ebbert JO; Hurt RD
J Subst Abuse Treat; 2011 Jan; 40(1):102-7. PubMed ID: 20947286
[TBL] [Abstract][Full Text] [Related]
2. Tobacco dependence treatment for hospitalized smokers: a randomized, controlled, pilot trial using varenicline.
Steinberg MB; Randall J; Greenhaus S; Schmelzer AC; Richardson DL; Carson JL
Addict Behav; 2011 Dec; 36(12):1127-32. PubMed ID: 21835552
[TBL] [Abstract][Full Text] [Related]
3. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
[TBL] [Abstract][Full Text] [Related]
5. Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study.
Bolliger CT; Issa JS; Posadas-Valay R; Safwat T; Abreu P; Correia EA; Park PW; Chopra P
Clin Ther; 2011 Apr; 33(4):465-77. PubMed ID: 21635992
[TBL] [Abstract][Full Text] [Related]
6. A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
Garza D; Murphy M; Tseng LJ; Riordan HJ; Chatterjee A
Biol Psychiatry; 2011 Jun; 69(11):1075-82. PubMed ID: 21295286
[TBL] [Abstract][Full Text] [Related]
7. Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.
Meszaros ZS; Abdul-Malak Y; Dimmock JA; Wang D; Ajagbe TO; Batki SL
J Clin Psychopharmacol; 2013 Apr; 33(2):243-7. PubMed ID: 23422399
[TBL] [Abstract][Full Text] [Related]
8. Varenicline and bupropion sustained-release combination therapy for smoking cessation.
Ebbert JO; Croghan IT; Sood A; Schroeder DR; Hays JT; Hurt RD
Nicotine Tob Res; 2009 Mar; 11(3):234-9. PubMed ID: 19246427
[TBL] [Abstract][Full Text] [Related]
9. Varenicline for smoking cessation: a placebo-controlled, randomized study.
Wang C; Xiao D; Chan KP; Pothirat C; Garza D; Davies S
Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221
[TBL] [Abstract][Full Text] [Related]
10. Observational study of safety and efficacy of varenicline for smoking cessation among Filipino smokers.
Park PW; Casiano EM; Escoto L; Claveria AM
Curr Med Res Opin; 2011 Oct; 27(10):1869-75. PubMed ID: 21838412
[TBL] [Abstract][Full Text] [Related]
11. Varenicline in smoking cessation.
Tonstad S; Rollema H
Expert Rev Respir Med; 2010 Jun; 4(3):291-9. PubMed ID: 20524911
[TBL] [Abstract][Full Text] [Related]
12. Sibutramine for weight gain attenuation during smoking cessation with varenicline: a pilot study.
Sood A; Ebbert JO; Clark MM; Croghan IT; Schroeder DR; Hays JT
Nicotine Tob Res; 2009 Dec; 11(12):1479-84. PubMed ID: 19884116
[TBL] [Abstract][Full Text] [Related]
13. A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial.
Wong J; Abrishami A; Yang Y; Zaki A; Friedman Z; Selby P; Chapman KR; Chung F
Anesthesiology; 2012 Oct; 117(4):755-64. PubMed ID: 22890119
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy.
Biazzo LL; Froshaug DB; Harwell TS; Beck HN; Haugland C; Campbell SL; Helgerson SD
Nicotine Tob Res; 2010 Jun; 12(6):567-73. PubMed ID: 20378640
[TBL] [Abstract][Full Text] [Related]
15. Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment.
Hajek P; Tønnesen P; Arteaga C; Russ C; Tonstad S
Addiction; 2009 Sep; 104(9):1597-602. PubMed ID: 19686530
[TBL] [Abstract][Full Text] [Related]
16. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
Lam S; Patel PN
Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
[TBL] [Abstract][Full Text] [Related]
17. Treatment of nicotine dependence with Chantix (varenicline).
Rankin KV; Jones DL
Tex Dent J; 2011 May; 128(5):457-61. PubMed ID: 21834368
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of varenicline as an aid to smoking cessation: results of an inter-European observational study.
Boudrez H; Gratziou C; Messig M; Metcalfe M
Curr Med Res Opin; 2011 Apr; 27(4):769-75. PubMed ID: 21294601
[TBL] [Abstract][Full Text] [Related]
19. Varenicline for tobacco dependence.
Cantrell MA; Geraets D
N Engl J Med; 2009 Feb; 360(7):730-1. PubMed ID: 19213691
[No Abstract] [Full Text] [Related]
20. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
Williams JM; Anthenelli RM; Morris CD; Treadow J; Thompson JR; Yunis C; George TP
J Clin Psychiatry; 2012 May; 73(5):654-60. PubMed ID: 22697191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
